Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDO2 | P48775 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5408629 | 0.80 | CYP1A1 (0.43) | MEN1KMT2AALDH1A1KDM4ETSHR | |
| SCHEMBL28133225 | 0.77 | ALDH1A1 (0.46) | MEN1KMT2AALDH1A1KDM4ETSHR | |
| SCHEMBL12539439 | 0.74 | TRPV3 (0.53) | KMT2AHPGDHTTHSD17B10SMN1; SMN2 | |
| SCHEMBL25228023 | 0.74 | TDO2 (0.55) | TDO2MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL30772447 | 0.73 | SQOR (0.49) | TDO2MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL4799732 | 0.73 | SQOR (0.49) | TDO2MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL9846087 | 0.73 | ALDH1A1 (0.42) | ALDH1A1KDM4ETSHRHPGDSMN1; SMN2 | |
| SCHEMBL4980644 | 0.73 | ERN1 (0.46) | KMT2AALDH1A1KDM4ETSHRHPGD | |
| SCHEMBL4799769 | 0.72 | TDO2 (0.54) | TDO2MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL3464851 | 0.72 | ERN1 (0.43) | ALDH1A1KDM4ETSHRHPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1730203-B1 | CATALYST COMPOSITION AND USE THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2008-12-31 | — | — | EP | disclosed |
| US-7423101-B2 | Catalyst composition and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-09-09 | — | — | US | disclosed |
| US-20080071047-A1 | Catalyst Composition And Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-03-20 | — | — | US | disclosed |
| US-7317057-B2 | Catalyst composition and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-01-08 | — | — | US | disclosed |
| EP-1730203-A1 | CATALYST COMPOSITION AND USE THEREOF | ExxonMobil Chemical Patents, Inc., A Corporation of the State of Delaware (US) | 2006-12-13 | — | — | EP | disclosed |
| WO-2005095469-A1 | CATALYST COMPOSITION AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-10-13 | — | — | WO | disclosed |
| US-20050209420-A1 | Catalyst composition and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209420-A1 | Catalyst composition and use thereof | DGAT1, DGAT2, ALOX5 | TDO2 365/4885MEN1 2901/4885KMT2A 3146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.